MedTrace Logo

Fat Reduction in the Flanks Area vs. Control

NCT02465775 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-04-14

No results posted yet for this study

Summary

Prospective, blinded, one arm, baseline-controlled clinical study for the evaluation the performance of the UltraShape treatment for non-invasive fat reduction by compare control and treated flanks.

Study subjects will undergo UltraShape treatments on one randomized flank using the U-Sculpt/VDF Transducer. The second flank will not be treated (control). Both flanks (treated and control) will be compared to baseline, as well as, one to each other

Conditions

  • Flanks Fat Reduction vs. Control

Interventions

DEVICE

UltraShape treatment

Fat cell destruction is achieved by ultrasound-induced mechanical effects during a very short exposure time.

Sponsors & Collaborators

  • Syneron Medical

    lead INDUSTRY

Principal Investigators

  • Robert Weiss, MD · 54 Scot Adams Road, Hunt Valley Baltimore USA

  • William P. Colem, MD · Coleman Center for Cosmetic Dermatologic Surgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-09-30
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02465775 on ClinicalTrials.gov